clinical trials
More News
-
PHC bans unauthorised plasma transfusion
Only hospitals approved by experts’ panel are allowed to offer treatment
-
First Chloroquine drug trial for COVID-19 unsuccessful
Hydroxychloroquine is a drug that scientists were optimistic will show improved symptoms for patients with COVID-19
-
China optimises treatment for COVID-19
Tocilizumab, with the common brand name Actemra, has been included in China's latest version of diagnosis
-
German expert for coronavirus 'brings virus inhibitors to China'
Rolf Hilgenfeld and his team have been devoted to research of SARS-CoV inhibitors for many years, says Chinese media
